Discussing TECENTRIQ (atezolizumab) with your healthcare team

Similar documents
YOUR GUIDE TO TECENTRIQ (atezolizumab) non-small cell lung cancer (NSCLC)

Discussing TECENTRIQ (atezolizumab) with your healthcare team Talking to Your Doctor

For the Patient: USMAVNIV

For the Patient: ULUAVPMB

For the Patient: USMAVPEM

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

system to help fight cancer Working with your immune

Get on with life, we ll see you. in 6 months. Living your life your way with MS

system to help fight cancer Working with your immune

For the Patient: USMAVFIPI

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

Is Avastin right for me? Make an informed decision about Avastin

Giving appropriate patients another chance to fight OPDIVO

All medicines have risks and benefits. Your doctor has weighed the risks of you being given Mabthera SC against the benefits expected for you.

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

Nivolumab. Other Names: Opdivo. About this Drug. Possible Side Effects (More Common) Warnings and Precautions

Package leaflet: Information for the patient. Bavencio 20 mg/ml concentrate for solution for infusion avelumab

Rheumatoid Arthritis Fact Sheet

Eloxatin Oxaliplatin concentrated solution for injection

Perjeta Contains the active ingredient pertuzumab (rch)

Have a healthy discussion. Use this guide to start a. conversation. with your. healthcare provider

Package leaflet: Information for the patient. KEYTRUDA 25 mg/ml concentrate for solution for infusion pembrolizumab

Important safety information to minimise the risk of immune-related adverse reactions

What do I need to tell my doctor BEFORE I take this drug?

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

This leaflet answers some common questions about HERCEPTIN SC. It does not contain all the available information.

Summary of the Risk Management Plan (RMP) V. 1.6, July 2017 for BAVENCIO. Avelumab 200 mg/10 ml. Concentrate for Solution for Infusion

WARNINGS AND PRECAUTIONS - COMBINATION OF OPDIVO AND YERVOY

WHAT IS OPDIVO USED FOR

What do I need to tell my doctor BEFORE I take this drug?

You should read this leaflet carefully and keep it in a safe place to refer to it later. WHAT IS OPDIVO USED FOR

If you have any concerns about using this medicine, ask your doctor or pharmacist.

JUST FOR KIDS SELECTED IMPORTANT SAFETY INFORMATION

Herceptin. Your guide to. for HER2-positive early breast cancer. (trastuzumab)

IMMUNOTHERAPY FOR THE TREATMENT OF LUNG CANCER

IMIPENEM+CILASTATIN RBX

acting aggressive, being angry or violent yourself, or feeling hopeless)

What You Need to Know About LEMTRADA (alemtuzumab) Treatment: A Patient Guide

MEDICATION GUIDE PegIntron (peg-in-tron) (Peginterferon alfa-2b) for injection, for subcutaneous use

Starting KAZANO gave me MORE POWER than metformin alone, with 2 medicines in 1 tablet

Inlyta (axitinib) for Kidney Cancer

Patient Information IXEMPRA Kit (pronounced as ǐk-'sĕm-pră) (ixabepilone) What is the most important information I should know about IXEMPRA?

Before you are given CYRAMZA. When you must not be given it

REMICADE Infliximab Consumer Medicine Information

RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets

Talking about your treatment. A guide to the conversations you may have before starting LEMTRADA

If you have any concerns about being given this medicine, ask your doctor or pharmacist.

Package leaflet: Information for the patient. KEYTRUDA 50 mg powder for concentrate for solution for infusion pembrolizumab

If you have any concerns about being given this vaccine, ask your doctor or pharmacist.

Your treatment with XELJANZ

MEDICATION GUIDE. The risk of getting a serious skin rash is higher if you:

For the Patient: Rituximab injection Other names: RITUXAN

What is the most important information I should know about bortezomib? What should I discuss with my healthcare provider before receiving bortezomib?

Consumer Medicine Information March 2009

For males: use effective birth control during your treatment with INLYTA. Talk to your doctor about birth control methods.

VELCADE Powder for Injection Bortezomib3.5 mg and 1 mg

Understanding your treatment and the side effects you may experience

Docetaxel (Taxotere )

RELISTOR. Methylnaltrexone bromide, Subcutaneous solution for injection. Consumer Medicine Information

PATIENT INFORMATION LEAFLET

o Your healthcare provider should test you for TB before starting CIMZIA.

METHYLDOPA 250 mg Film-coated Tablets

Capecitabine. Other Names: Xeloda. About This Drug. Possible Side Effects. Warnings and Precautions

PART III: CONSUMER INFORMATION

of LDL and HDL cholesterol.

If you have any concerns about taking this medicine, ask your doctor or pharmacist.

Summary of the risk management plan (RMP) for Nivolumab BMS (nivolumab)

(sunitinib malate) for Kidney Cancer

ATORIS 10, 20, 40 mg film-coated tablets

YERVOY (yure-voy) Ipilimumab (ipi-lim-u-mab)

PHARMA DYNAMICS CLOPIDOGREL 75 mg PATIENT INFORMATION LEAFLET

For the Patient: Amsacrine Other names: AMSA PD

Ezetimibe Sandoz Ezetimibe 10 mg tablet

Nivolumab. Nivolumab

ILOMEDIN (I lom ED in) iloprost (as trometamol)

Managing a UCD Video: Transcript. Ammonia. Urea. Liver graphic. RAVICTI logo

For the Patient: Adjuvant therapy for breast cancer using weekly paclitaxel and trastuzumab (Herceptin)

QUESTIONS TO ASK MY DOCTOR

Preparing for Your Immune Checkpoint Inhibitor (CPI) Treatment

FDA-approved Medication Guide MEDICATION GUIDE. RIBASPHERE (Rīb-ă-sphere) Tablets

FDA APPROVED MEDICATION GUIDE

KAMIREN PACKAGE LEAFLET: INFORMATION FOR THE USER. What is in this leaflet? 1. WHAT KAMIREN IS AND WHAT IT IS USED FOR

DBL Docetaxel, Concentrated Injection

This leaflet answers some common questions about PNEUMOVAX 23 (pronounced new-mo-vax). It does not contain all the available information.

OncoTICE powder for suspension 2-8 X 10 8 CFU Tice BCG. 1. What Oncotice is and what it is used for. 2. Before you are given Oncotice

MEDICATION GUIDE SUTENT

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

Medication Guide. VIDEX EC (VY-dex Ee-see) (didanosine, also known as ddi) Delayed-Release Capsules Enteric-Coated Beadlets

What do I need to tell my doctor BEFORE I take this drug? If you have an allerg y to ofatumumab or any other part of this drug.

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. SYLVANT pronounced SILL-vant siltuximab for injection

Do not g ive this drug if your child has an infection or any inflammation.

Sunitinib. Other Names: Sutent. About This Drug. Possible Side Effects. Warnings and Precautions

PRIMAXIN Imipenem/Cilastatin sodium

Treatment Journal. Therapy Tracker TREATMENT JOURNAL

J. Van Lier Ribbink, M.D., F.A.C.S. Center for Endocrine and Pancreas Surgery at Honor Health

I. ALL CLAIMS: HEALTH CARE PROFESSIONALS

Medication Guide Enbrel (en-brel) (etanercept)

Transcription:

Discussing TECENTRIQ (atezolizumab) with your healthcare team What is TECENTRIQ? TECENTRIQ is a prescription medicine used to treat: a type of lung cancer called non-small cell lung cancer (NSCLC). TECENTRIQ may be used when your lung cancer: has spread or grown, and you have tried chemotherapy and it did not work or is no longer working. It is not known if TECENTRIQ is safe and effective in children.

Questions to ask your healthcare professional: Questions about your diagnosis 1. What kind of cancer do I have? 2. What stage is my cancer? 3. What is the time frame for me to make decisions regarding treatment? 4. If I decide to have treatment, when can I start? What are my treatment options? 1. What are the usual treatment options for someone with my type of cancer? 2. Are there any newer treatments that are not funded that may benefit me? 3. How long will I need to stay on these treatments? 4. How will I know my treatment is working? 5. What are the chances my cancer will come back after treatment?

Questions to ask your healthcare professional: Is TECENTRIQ right for me? 1. What is immunotherapy? 2. Is immunotherapy a suitable treatment option for my cancer? 3. How does TECENTRIQ work? 4. How do I get TECENTRIQ if it is not available in a public hospital? 5. Who can I talk to regarding funding/health insurance to help me pay for TECENTRIQ? 6. How long will I need to be on TECENTRIQ? 7. How will I know if TECENTRIQ is working? 8. What are the side effects of TECENTRIQ?

Notes:

TECENTRIQ Consumer Panel TECENTRIQ (atezolizumab), 1200mg/20mL, is a Prescription Medicine used for advanced or metastatic (spreading) non-small cell lung cancer, and advanced or spreading urothelial cancer (a type of cancer that affects the bladder and urinary system). Do not use TECENTRIQ if: you have had an allergic reaction to TECENTRIQ or any of the ingredients in the vial. Tell your healthcare professional if: you have immune system problems such as Crohn s disease, ulcerative colitis, or lupus; you have inflammation of the lungs (called pneumonitis ); you have liver problems, such as hepatitis; you have thyroid problems; you are taking other medicines; you are pregnant or breast-feeding, or plan to become pregnant or breast-feed. Tell your healthcare professional right away if you become pregnant during treatment with TECENTRIQ. Tell your healthcare professional immediately or go to your nearest Accident and Emergency Centre if you notice any of the following: inflammation of the lung (pneumonitis): symptoms may include new or worsening cough, shortness of breath, and chest pain; inflammation of the liver (hepatitis): symptoms may include yellowing of skin or eyes, nausea, vomiting, bleeding or bruising, dark urine, and stomach pain; inflammation of the intestines (colitis): symptoms may include diarrhoea (watery, loose or soft stools), blood in stools, and stomach pain; inflammation of the thyroid and adrenal glands (hypothyroidism, hyperthyroidism, or adrenal insufficiency): symptoms may include tiredness, weight loss, weight gain, changes in mood or behaviour, hair loss, constipation, headache, and dizziness; type 1 diabetes mellitus, including acid in the blood produced from diabetes (diabetic ketoacidosis): symptoms may include feeling more hungry or thirsty than usual, need to urinate more often, weight loss, and feeling tired; inflammation of the brain (encephalitis) or inflammation of the membrane around the spinal cord and brain (meningitis): symptoms may include neck stiffness, headache, fever, chills, vomiting, eye sensitivity to light, confusion and sleepiness; inflammation or problems of the nerves (neuropathy): symptoms may include muscle weakness, numbness or tingling in hands and feet; inflammation of the pancreas (pancreatitis): symptoms may include abdominal pain, nausea and vomiting; severe reactions associated with infusion (events occurring during or within one day of having the infusion) may include fever, chills, shortness of breath and flushing. Possible common side effects may also include: joint pain; loss of appetite; diarrhoea; shortness of breath; feeling tired with no energy (fatigue); itching of the skin; nausea; fever; rash; vomiting; difficulty swallowing; flu-like symptoms; nasal congestion; stomach pain; pain in the muscles and bones. TECENTRIQ has risks and benefits. Ask your healthcare professional if TECENTRIQ is right for you. Use strictly as directed. If symptoms continue or you have side effects, see your healthcare professional. For further information on TECENTRIQ, please talk to your health professional or visit www.medsafe.govt.nz for TECENTRIQ Consumer Medicine Information. TECENTRIQ is not funded by PHARMAC. You will need to pay the full cost of this medicine. A prescription charge and normal oncologist fees may apply. Consumer Panel based on CMI dated 07 April 2017. All trademarks mentioned herein are protected by law. PM-NZ-0307/TAPS/NA-9956/2018APR Roche Products (New Zealand) Limited, Auckland. 0800 656 464 www.roche.co.nz